- Home
- JAZZ vs SITE Comparison
JAZZ vs SITE Comparison
Compare JAZZ & SITE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- SITE
- Stock Information
- Founded
- JAZZ 2003
- SITE 2013
- Country
- JAZZ Ireland
- SITE United States
- Employees
- JAZZ N/A
- SITE N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- SITE Professional and commerical equipment
- Sector
- JAZZ Health Care
- SITE Consumer Discretionary
- Exchange
- JAZZ Nasdaq
- SITE Nasdaq
- Market Cap
- JAZZ 7.1B
- SITE 6.1B
- IPO Year
- JAZZ 2007
- SITE 2016
- Fundamental
- Price
- JAZZ $124.15
- SITE $144.57
- Analyst Decision
- JAZZ Strong Buy
- SITE Buy
- Analyst Count
- JAZZ 12
- SITE 10
- Target Price
- JAZZ $182.75
- SITE $146.40
- AVG Volume (30 Days)
- JAZZ 879.8K
- SITE 545.2K
- Earning Date
- JAZZ 08-05-2025
- SITE 07-30-2025
- Dividend Yield
- JAZZ N/A
- SITE N/A
- EPS Growth
- JAZZ N/A
- SITE N/A
- EPS
- JAZZ N/A
- SITE 2.74
- Revenue
- JAZZ $4,086,695,000.00
- SITE $4,622,900,000.00
- Revenue This Year
- JAZZ $5.65
- SITE $6.20
- Revenue Next Year
- JAZZ $5.79
- SITE $4.54
- P/E Ratio
- JAZZ N/A
- SITE $52.41
- Revenue Growth
- JAZZ 4.52
- SITE 4.38
- 52 Week Low
- JAZZ $95.49
- SITE $101.25
- 52 Week High
- JAZZ $148.06
- SITE $160.75
- Technical
- Relative Strength Index (RSI)
- JAZZ 66.76
- SITE 58.90
- Support Level
- JAZZ $122.50
- SITE $140.80
- Resistance Level
- JAZZ $126.14
- SITE $147.45
- Average True Range (ATR)
- JAZZ 2.50
- SITE 4.39
- MACD
- JAZZ 0.80
- SITE 0.13
- Stochastic Oscillator
- JAZZ 87.44
- SITE 84.75
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About SITE SiteOne Landscape Supply Inc.
SiteOne Landscape Supply Inc is a supplier of tools and equipment. The company serves various businesses which include wholesale irrigation, outdoor lighting, nursery, landscape supplies, grass seeds, and fertilizers, turf protection products, turf care equipment, and golf course accessories for green industry professionals mainly in the United States and Canada. Its product portfolio includes irrigation supplies, fertilizer and herbicides, landscape accessories, nursery goods, natural stones and blocks, outdoor lighting and ice melt products and other products.